Covid-19: the French Bioclusters network unveil a national initiative map.
Strasbourg, Paris, Lyon, Lille, Nantes, Marseille, 7th May 2020 – The six health competitiveness clusters – Atlanpole Biotherapies, BioValley France,... View Article
New member | Hawkcell
HawkCell is a CRO that provides in vivo MRI services on animals (from 1 to 150kg). We extend the potential... View Article
Horama | 3 experts have just joined the team
HORAMA, a clinical stage gene therapy company in ophthalmology, announced several appointments in recent weeks : Rodolphe Clerval has been... View Article
CEBR & COVID-19 | Webinars
CEBR members are key actors in looking for solutions to improve the current COVID situation, locally but also at EU... View Article
Xenothera news
XENOTHERA, created in 2014, is a Nantes-based biotech company which develops “humanized” polyclonal antibodies. Their technological platform is based on... View Article
GlioCure finalises its seed capital with a financing from « French Tech Seed » and reports a second consecutive profitable year
Angers, May 12th, 2020 – GlioCure SAS, a biotech company specialised in neuro-oncology, held its ordinary Annual General Meeting, and... View Article
ENEN+ PROJECT
Attract, Retain and Develop New Nuclear Talents beyond Academic Curricula The ENEN+ project, co-funded by the EURATOM research and training... View Article
OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
OSE Immunotherapeutics announced that the Company is committed to the fight against COVID-19. Its team of immunologists is actively working... View Article
Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
Phase 2 vaccine candidate, VLA15, is being evaluated for adult and pediatric indications in North America and Europe. Saint Herblain... View Article
Rare Diseases Research Challenges Call for proposals
The French Foundation for Rare Diseases, partner of the European Joint Programme for Rare Diseases EJPRD, is pleased to announce... View Article